Skip to main content
. Author manuscript; available in PMC: 2005 Sep 13.
Published in final edited form as: Immunol Invest. 2004 May;33(2):213–233. doi: 10.1081/imm-120034231

Figure 2. p38 MAPK phosphorylation is dose-dependently inhibited by SB203580.

Figure 2

MC3T3-E1 cells were serum starved, then treated with SB203580 at indicated concentrations for 30 minutes, and then stimulated for 20 minutes with IL-1β (1ng/ml). Whole cell extracts were analyzed by Western blot with antibodies against phosphorylated and non-phosphorylated p38 MAPK. Data is representative experiment preformed independently three times with similar results.